SOLIGENIX Trademark

Trademark Overview

On Thursday, May 23, 2013, a trademark application was filed for SOLIGENIX with the United States Patent and Trademark Office. The USPTO has given the SOLIGENIX trademark a serial number of 85983280. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 19, 2025. This trademark is owned by Soligenix, Inc.. The SOLIGENIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
soligenix

General Information

Serial Number85983280
Word MarkSOLIGENIX
Filing DateThursday, May 23, 2013
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 19, 2025
Registration Number4766782
Registration DateTuesday, July 7, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2013

Trademark Statements

Goods and ServicesResearch and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2013
Primary Code042
First Use Anywhere DateFriday, September 30, 2011
First Use In Commerce DateFriday, September 30, 2011

Trademark Owner History

Party NameSoligenix, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameSoligenix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameSoligenix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Monday, September 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 27, 2013NEW APPLICATION ENTERED
Wednesday, June 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 9, 2013ASSIGNED TO EXAMINER
Wednesday, October 2, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2013PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 28, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 28, 2014NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 28, 2014TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 28, 2014DIVISIONAL REQUEST RECEIVED
Monday, December 1, 2014ASSIGNED TO EXAMINER
Wednesday, December 17, 2014DIVISIONAL PROCESSING COMPLETE
Sunday, July 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 17, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, February 12, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 29, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 13, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 13, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 13, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 22, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, September 19, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 19, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 19, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 19, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

soligenix research vaccines development fields immunopharmaceuticals services engineering medicines testing